Assesses zinc oxide nanoparticles' effects on neutrophils in liver fibrosis, suggesting potential therapeutic benefits.
(sumac) green-synthesized zinc oxide nanoparticles (ZnO-NPs) on circulating neutrophils and the histological structure of liver in carbon tetrachloride (CCl4) treated rats. CCl4 rats showed biochemical changes and histopathological damage, together with increased neutrophil markers [myeloperoxidase (MPO) and citrullinated histone (H3cit)] as well as decreased neutrophils' phagocytic activity and miR-223 expression compared to control. ZnO-NPs treatment was significantly associated with biochemical and histopathological improvement, decreased neutrophil markers, and increased both phagocytic activity and miR-223 expression. In addition, green-synthesized ZnO-NPs were associated with greater histopathological improvement and a significant increase in miR-223 expression in comparison to chemically prepared ZnO-NPs. It can be concluded that ZnO-NPs may have immunomodulatory effects on circulating neutrophils that have a biological impact on disease progression. In addition, green-synthesized ZnO-NPs may be more efficient than chemically synthesized ones at providing a greater modulatory effect on circulating neutrophils and better hepatoprotective effects.
No takes yet. Share an insight, caveat, or question.
Youssry et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: